[1]
“Biomedical Consideration in the Manufacture, Clinical Trial and Bioequivalence Studies of Pharmaceuticals”, Bangladesh J Bioethics (BJBio), vol. 2, no. 1, pp. 18–21, Feb. 2012, doi: 10.3329/bioethics.v2i1.9813.